WHO Cervical Cancer Prevention and Control Costing (C4P) Tool

WHO Cervical Cancer Prevention and Control Costing (C4P) Tool

WHO / Blink Media - Ricci Shryock
© Credits

Background

The Department of Immunization, Vaccines and Biologicals (IVB) in WHO has developed a generic costing and planning tool for cervical cancer prevention and control. The WHO Cervical Cancer Prevention and Control Costing (C4P) tool has been developed specifically to assist low- and middle-income countries in planning and costing cervical cancer control strategies. The tool has been built in Microsoft Excel and consists of two independent modules.

  1. HPV vaccination module (C4P-HPV tool)
  2. Cervical cancer screening and treatment module (C4P-ST tool)

Both modules generate financial and economic cost estimates for programmes, either to project future costs or to retrospectively evaluate programme spending. The costs are broken down by cost activity components.

The C4P-HPV tool is used for estimating the additional resources required to introduce HPV vaccine into an existing immunization programme for a five-year scale-up. The cost output is displayed in terms of total costs and costs per fully immunized person. Both introduction and recurrent costs are available to assist programme planning.

The C4P-ST tool estimates additional resources required to add cervical cancer screening and treatment to an existing health programme, and provides estimates of cost per screening or treatment service over a five-year period.

The WHO C4P tool provides access to transparent underlying calculations and assumptions. The C4P-HPV tool is currently available in English and French by selecting preferred language within the tool; and the C4P-ST tool is currently available in English.

Potential target audiences of the WHO C4P tool include: mediators (i.e., international consultants, technical assistants and trainers) of costing and planning activities, supervisors, sponsors, and managers of costing and planning activities, developers of costing and planning tools, subject matter experts in cervical cancer prevention and control programming, and subject matter experts in costing and planning.


Human papillomavirus (HPV) vaccination module (C4P-HPV tool):

C4P HPV toll cover
The C4P-HPV tool is one of the modules of the WHO Cervical Cancer Prevention and Control Costing (C4P) tool which has been developed specifically to assist...
User manual for WHO cervical cancer prevention and control costing tool: HPV vaccination module (‎C4P-HPV tool)‎
This WHO Cervical Cancer Prevention and Control Costing (C4P) tool consists of two independent modules: human papillomavirus (HPV) vaccination and cervical...

Cervical cancer screening and treatment module (C4P-ST tool):

New C4P Tool: Screening and Treatment Module
The C4P-ST tool is one of the modules of the WHO Cervical Cancer Prevention and Control Costing (C4P) tool which has been developed specifically to assist...

User manual:

Improving data for decision-making: a toolkit for cervical cancer prevention and control programmes
This publication, Improving data for decision-making: a toolkit for cervical cancer prevention and control programmes, expands the support provided to...

Please refer to Section n. 5

Development

An early version of the C4P-HPV tool was used for Gavi-supported demonstration projects on sub-national level costing. A version was then developed for national scale-up of HPV vaccination, which was successfully field tested in the United Republic of Tanzania and Rwanda and later refined following a workshop attended by representatives of five WHO regions in 2011. The refined tool was reviewed by the Immunization and Vaccine related Implementation Research Advisory Committee (IVIR-AC) in September 2012.

Major updates in both modules have been implemented in 2019 and a modified tool has also been field tested in the United Republic of Tanzania, Myanmar and Uzbekistan in this same year. The tool continues to be updated in response to feedback from WHO consultants and other users.

 

Incorporation into other tool(s)

In addition to being available on its own, the C4P-HPV tool has also been incorporated into the OneHealth tool to allow consideration of HPV vaccine introduction in the context of other national health programmes.

The OneHealth tool is a single framework for all major diseases and health components that estimates the health inputs, resources and costs of national strategic health plans in low- and middle-income countries. The OneHealth tool is available from Avenir Health and more information is available from WHO-CHOICE.


Disclaimer

The C4P tool produces cost estimates to aid decision making in HPV and cervical cancer prevention and control strategies. Although every effort has been taken to ensure that the cost estimate is representative of actual spending, the C4P estimate cannot be interpreted as the actual expenditure of the programme.

The results calculated with this tool depend on the assumptions and values entered by its users. They do not represent official results from the WHO and the users of the tool alone are responsible for the results they generate with it.

WHO does not warrant or represent that the information in this tool is free from errors or omissions or is suitable for your intended use. This disclaimer applies to all information within this tool, including but not limited to example workbooks, workbook content, user manuals, training, and resources.

WHO recommends that you seek independent advice before relying upon or acting on any information in this tool. WHO accepts no responsibility for any loss, damage, cost or expense (whether direct or indirect) incurred by you as a result of any error, omission or misrepresentation in any information in this tool.

 

Related publications

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (‎HPV)‎

This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer....

Guidelines for the management of symptomatic sexually transmitted infections

The WHO global health sector strategy on sexually transmitted infections (STIs), 2016–2021, endorsed by the World Health Assembly in 2016, aims to...

The Cervical Cancer Prevention and Control Costing (C4P) Tool is intended specifically to assist low and middle-income country programme managers in planning...

The objective of this costing exercise, which began in 2018, is to assist refinement and implementation of Myanmar’s national plan for secondary...

This current costing exercise assists in the implementation of the National Response to Cervical Cancer 2020—2024 in Tanzania and supports the development...

Resulting from a collaboration between the Mongolia Ministry of Health and the World Health Organization (WHO), this document provides a summary report...

Zambia is already a regional leader in scaling up cervical cancer control in all three pillars of primary, secondary, and tertiary prevention. With an...

The results reported illuminate the additional resources and expenditures required under the 2017—2021 Plan and helps inform government planners...

Cervical Cancer Elimination Initiative

Cervical Cancer Elimination Initiative

HPV Vaccine Introduction Clearing House

HPV Vaccine Introduction Clearing House